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In 2019, plasma centers in the United States received a record 53.5 million
blood donations, roughly triple that collected during the Great Recession.
Recent ethnographic research and journalistic accounts connect plasma sales
and poverty, an association that would carry important public health implications given the vulnerability of disadvantaged populations. This study is
the first to examine a range of socioeconomic characteristics of communities
where commercial plasma centers situate. We geocode locations of all U.S.
commercial plasma centers and merge with census tract demographic data
from the American Community Survey. Findings indicate greater odds that
plasma centers will locate in urban tracts with high rates of deep poverty,
poverty, and near poverty. There is a bivariate association with high percentages of residents identifying as Black and Hispanic. These findings indicate
a clear interrelationship between persistent economic hardship and the raw
material sustaining a major healthcare industry.
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In 2019, plasma centers in the United States received a record
53.5 million paid plasma donations, roughly three times than what
was recovered during the Great Recession. (Plasma Protein Therapeutics Association, 2011, 2019). The number of plasma donation
centers have expanded from fewer than 300 in 2005 to over 900 in
2020, supporting a growing industry that was worth $4 billion in
2008, $21 billion in 2016, and is forecast to reach $48 billion by 2025
(Hotchko & Robert, 2018; Market Research Bureau, 2020; Mitchum,
2008; U.S. Food and Drug Administration [FDA], 2020; Wellington,
2014). Ethnographic research and journalistic accounts suggest that
a key motivating factor fueling plasma donation in the U.S. is the
financial compensation associated with the transaction (Edin &
Shaefer, 2015; Goldstein, 2017; Guendelsberger, 2019; Kretzmann,
1992; Tirado, 2014; Valiente et. al., 2017).
These accounts suggest that paid plasma donation has become
a common economic coping strategy among Americans with low
incomes, who over the past decades have experienced: high rates of
poverty and hardship; steep increases in the costs of essential expenses; declines of the cash safety net; and a corresponding rise in
extreme poverty (Edin & Shaefer, 2015; Valiente et.al., 2017; Wellington, 2014; Woolf et. al., 2006). Because U.S. Food and Drug Administration (FDA) regulations permit American donors to sell plasma
up to twice a week (U.S. FDA, 2019), these donations can add a few
hundred dollars a month to household income, an important source
of economic support for low-income families.
Despite the large growth in plasma donations since the Great
Recession, recent literature has not examined the demographic
characteristics of the growing number of plasma donors, reportedly
low-income Americans who are already prone to poor health outcomes (National Center for Health Statistics, 2012). Such evidence
would hold clear public health implications, particularly given the
limited evidence on the impact of plasma donation on donor health.
In the absence of publicly available data on the characteristics of
plasma donors, this study examines the socioeconomic characteristics of the communities where plasma centers are situated.
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Background
Plasma donation, or plasmapheresis, is a procedure that involves
the extraction of plasma from the blood for the use of medical therapies. The plasma exclusively extracted from voluntary donors is
known as source plasma, defined by the FDA as the fluid portion of
human blood intended as source material for further manufacturing use (U.S. FDA, 2019). Plasma is used in medical therapies called
plasma protein therapies (PPT) (Market Research Bureau, 2018).
These therapies primarily benefit patients suffering from rare diseases (namely antibody deficiencies) and hemophiliacs (Farrugia &
Robert, 2006).
As worldwide demand for plasma-derived therapies has expanded, so has the presence of plasma centers across the U.S. (Hotchko & Robert, 2018). The global plasma industry relies heavily on
U.S. donors, because the U.S. holds the least restrictive plasma regulations in the world (Hotchko & Robert, 2018; Robert, 2017). A single U.S. donor can yield far more donations than in any other country because most countries limit plasma donation to once every 2
weeks and prohibit paid donation (The Lancet Haematology, 2017). In
2016, the United States accounted for 74% of the world’s source plasma supply, while North America accounted for 44 percent of the
demand (Hotchko & Robert, 2018; Robert, 2017), meaning plasma
from U.S. donors is used all across the world.
Figure 1 charts total paid plasma donations in the United States
by year, 1999–2019. While the number of donations remained steady
between 1999 and 2005—with some slight counter-cyclical variation—donations began to increase rapidly starting after 2006, quadrupling by 2018.
Health Implications of Plasma Donation
The limited evidence available on the impact of plasma donation on donor health focuses on: (1) the linkage between plasma donation and distribution of risk behaviors associated with
transfusion-transmissible infections; and (2) donor physiological
health implications. In an earlier paper examining the location of
commercial plasma centers in the U.S. from the period 1980–1995
relative to geographic distribution of risk behaviors, Robert C.
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Figure 1: US Source Plasma Collections 1999–2019
Source: Plasma Protein Therapeutics Association 2011 and 2019
James and Cameron Mustard (2004) found that commercial plasma
centers were overrepresented in neighborhoods with very active
drug economies. These neighborhoods had high concentrations of
households in deep poverty—with incomes below half the official
poverty threshold. That this pattern persisted even after contaminated plasma products had infected thousands of patients with
HIV and Hepatitis C was an alarming finding (HIV and Hepatitis C
testing was not readily available during this time period). Technological advancements since the 1990s that introduced viral inactivation techniques during the production of plasma derivatives manufactured from paid donors have made blood products safer for
patients (World Health Organization, 2004). However, ethnographic research and journalistic accounts of plasma donors suggest that
plasma donation is still primarily undertaken by vulnerable populations (Edin & Shaefer, 2015; Valiente et. al., 2017).
With regards to the impacts of plasma donation on donor health,
short-term side effects such as fatigue, tingling sensations, anemia,
and black outs have been chronicled in firsthand accounts published
in The New York Times, The Atlantic, and Huffington Post (Greenberg,
2019; McCollum, 2020; Wellington, 2014). Additional physiological
implications were examined in a 1994 study that sought to determine
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whether long-term plasma donation altered plasma proteins or lymphocyte phenotypes (Lewis et al., 1994). The authors found that
plasma donors had increased percentages of B cells as compared to
non-donor controls and whole blood donors. The authors hypothesized that the increase in B cells may be a compensatory mechanism
to make more immunoglobulin to replace what was lost in plasmapheresis, suggesting physiological consequences to plasma donation.
Another study found that performance in exhaustive, severe-intensity exercise was “markedly reduced immediately following the removal of plasma. The only likely explanation is that anaerobic energy pathways must have been compromised” (Hill et. al., 2013, p. 554).
This study measured time to exhaustion before and after plasma donation at different time intervals. The authors noted that while performance declined initially, performance levels were re-established
thereafter. However, because each participant only donated plasma
once during this study, possible consequences of repeated withdrawals could not be determined.
A 2010 study investigating the long-term effects of plasma donation in the United States found that high frequency U.S. plasma
donors had fewer proteins in their blood when compared to European plasma donors (Hellstern et al., 2001). In this study, all subjects were regular plasmapheresis donors over a period of at least
6 weeks. The median interval between two plasma donations was
5 days among U.S. donors and 14 days along German donors. The
results indicate that plasma collected from frequent donors yielded
lower quality plasma.
In another study that examined the risk of iron depletion among
frequent plasma donors, the authors found that frequent source
plasma donation in the U.S. did not adversely impact iron stores
(Schreiber et al., 2018). However, donor samples were taken once
at the beginning of the donor’s routine plasma donation instead of
after, and the period of time between which the donor had last given plasma and the sample was not considered. These factors lead
to questions about the validity of the results of this study. It is also
important to note that the study was a collaborative effort between
the Plasma Protein Therapeutics Association and other leaders in
the plasma industry.
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Data and Statistical Methods
To examine the association between the location of plasmapheresis centers and the demographic characteristics of the surrounding
communities, the addresses of active (as of May 2017) FDA-approved
plasmapheresis centers were geocoded and analyzed in 2017–2019
in conjunction with Census tract level data from the American
Community Survey (ACS) (2011–2015 5-year estimates) using ArcGIS. The ACS is a nationally-representative household survey conducted by the U.S. Census Bureau that randomly samples addresses
in every state, the District of Columbia, and Puerto Rico. The ACS is
the primary source of data for the socio-economic characteristics of
small units of geography (U.S. Census Bureau, 2018). In addition, to
provide a population density measure, primary rural-urban commuting area (RUCA) codes classifications were incorporated in our
data set. RUCA codes classify U.S. census tracts using measures of
population density, urbanization, and daily commuting. Primary
codes range from a whole number scale of 1–10 to delineate metropolitan, micropolitan, small town, and rural commuting areas. The
RUCA codes used in this study are from the 2010 decennial census.
Plasma center addresses were retrieved from the U.S. Food and
Drug Administration’s Blood Establishment Registration Database
in May 2017 (U.S. FDA, 2017). Geocoding these addresses revealed
638 locations throughout the continental United States. Of these
centers, eight were not-for-profit establishments and one was located in a tract with no population. These nine centers were dropped
from the dataset. Our data consists of the remaining addresses of
629 commercial plasmapheresis centers. Data were sorted into two
groups: (1) Census tracts with plasma centers; and (2) Census tracts
without plasma centers. There were initially 72,065 census tracts in
our data set. Of these, 331 tracts were dropped because they had no
population, 473 tracts were omitted because they had unreported
poverty data, and an additional two tracts were dropped because
they were missing data on educational attainment. This left 71,590
census tracts. Of these, 617 census tracts had plasma centers and
70,973 did not.
Two sample t-tests were used to assess statistical significance of
differences in selected characteristics. Logistic regression was then
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employed to estimate the association of community characteristics—
such as racial and ethnic composition, educational attainment, poverty status, and population density—with the presence of a plasma
center in that community. The outcome variable indicated whether
or not a plasma center existed in the census tract (1 = yes, 0 = no).
Race and ethnicity were measured using the following variables
from the ACS: total percent White alone, total percent non-Hispanic
black, total percent Hispanic, and total percent other (this is the aggregate of all categories other than non-Hispanic black and Hispanic). The educational attainment variable was measured using the
following variables, as a proportion of the census tract population:
level of education less than high school, level of education more
than high school and some college, and Bachelor’s degree of more.
Poverty was measured by variables of the proportion of people living below cash incomes of 50% of the poverty line, 50–99.9%, and
100–200% of the poverty line. Population density was measured by
a dichotomous variable constructed from 2010 RUCA codes. RUCA
codes 1–3 denote metropolitan areas, 4–6 denote micropolitan areas, 7–9 denote small towns, and 10 denotes rural areas. We created
an urban variable which categorizes RUCA codes 1–3 as urban (urban = 1) and codes 4–10 as not urban (urban = 0). Lastly, a variable
for state was included in model 3 to control for underlying state
characteristics.

Results
Figure 2 plots the locations of commercial plasmapheresis centers in the continental United States. Concentrations of plasma centers exist in the South and Midwest. As per FDA blood establishment registration records, Texas had the highest number of active
plasma centers of any state in the United States (84), with many
along the southern border, followed by Florida (47). The upper
Northeast and West regions exhibited lower concentrations.
Results from Table 1 indicate that 597 census tracts with plasma
centers are located in urban areas and 20 are located in rural areas.
While 96.8 percent of plasma centers are located in urban areas, only
82.0 percent of all census tracts in the United States are urban. Another primary difference between the two groups of census tracts is
in the concentration of racial and ethnic minorities. Non-Hispanic
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Figure 2: Location of plasma centers and proportion of county population living below 100% poverty level
Blacks make up 21.5 percent of the population in census tracts with
plasma centers, compared to 13.4 percent of those without plasma
centers. The results are similar for Hispanic origin. In contrast,
while 50.8 percent of residents in census tracts with plasma centers are non-Hispanic White, the proportion of non-Hispanic White
residents is 12 percentage points higher in census tracts without
plasma centers at 62.8.
The differences are not as striking by educational attainment, although they move in the hypothesized direction. A somewhat larger
proportion of residents in census tracts with plasma centers had not
graduated from high school (16.8 percent versus 13.7 percent) and
correspondingly a somewhat lower fraction had a bachelor’s degree
(29.0 percent versus 23.9 percent). The rates of high school degree attainment and some college are roughly comparable.
Those living in census tracts with plasma centers were also
more likely to live in poverty, most noticeably deep poverty, below
50% of the poverty line, and below 100% of the poverty line. While
on average 7.3 percent of the population residing in census tracts
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Table 1. Selected Socio-economic Characteristics for Census Tracts
with and without plasma centers (Means)
No plasma centers

With plasma centers

Standard
Standard
Deviation
Deviation Mean
.386
.968

Standard
Standard
Deviation
Deviation t
.177
-9.6*

Characteristics
Urban (dichotomous)

Mean
.818

Race and Ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other

62.8
13.4
16.1
7.8

30.0
21.7
21.3
10.2

50.8
21.5
20.7
6.9

28.6
25.1
24.7
6.1

9.9*
-9.3*
-5.4*
2.0*

Educational Attainment
< High School
HS, Some college, No BA
Bachelor’s degree +

13.7
57.3
29.0

11.0
14.3
18.8

16.8
59.3
23.9

11.7
10.8
14.6

-7.0*
-3.5*
6.8*

7.3
8.9
19.0
64.8

7.0
7.1
9.4
18.9

12.0
13.4
23.8
50.8

10.0
7.9
8.3
18.9

-16.7*
-15.6*
-12.7*
18.4*

Income-to-Poverty
< 50% poverty
50 to <100% poverty
101 to 199% poverty
>200% poverty
* p<0.05 or beyond

Source: Census tract data retrieved from ACS 2011-2015 (5-year estimates) and plasma
center addresses retrieved from FDA Blood Establishment Registration Database on May
31, 2017
Notes: Table 1 compares the socio-economic characteristics for census tracts with and
without plasma centers. The table shows statistically significant results at p=0.5 for all
selected socioeconomic characteristics.
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without plasma centers live below half the poverty line, 12.0 percent of those in census tracts with plasma centers did so, a figure
64 percent higher. The rate of residents between 50 and 100% of
poverty was 51 percent higher in tracts with a plasma center than
in tracts without plasma centers.
Table 2 reports the results from three multivariate logistic regression models that estimate the odds that a plasma center will be
located in a census tract. Census tracts are the unit of observation,
and the dichotomous outcome is equal to 1 if there is a plasma center in the census tract, and 0 if there are no plasma centers present. Model 1 includes poverty, race and ethnicity variables. Model
2 adds educational attainment, and model 3 includes all variables
in the previous models, adds a variable indicating urbanicity, and
controls for states to adjust for underlying state characteristics. State
coefficients have been omitted from the table. In each model, standard errors are clustered by state.
The odds ratios for all the poverty variables (below 50% poverty,
50–99% and 100–200%) in each model are substantively meaningful
and all are statistically significant at p<0.01 across all three model
variations; the odds of finding a plasma center in census tracts is
positively associated with the proportion of individuals living in
deep poverty, poverty, and near poverty. Odds ratios for all three
levels of poverty are roughly similar in magnitude.
With regard to race and ethnicity, when income-to-poverty
variables and race and ethnicity are entered into the same model,
the bivariate differences seen by race and ethnicity in Table 1 are
not evident. In no model is the percentage of Black non-Hispanic
population associated with greater odds of a plasma center. In
model three, the odds of a plasma center are somewhat higher and
are statistically significant for the percent Hispanic only. Thus, of
the inter-related factors of community-level poverty rates and composition by race and ethnicity, poverty appears to be the stronger
predictor in these models.
Interestingly, the odds associated with higher levels of educational attainment (percent high school and/or some college and percent more than BA) are above one, and are statistically significant at
above the .001 level. In models two and three, the odds of finding a
plasma center in areas where a greater proportion of the population
has some college as well as a bachelor’s degree are greater when
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Table 2: Odds Ratios From Logistic Regression Models: Predicting
the Association of Characteristics of Communities With Presence of
aTable
Plasma
Center
That
Community
2: Odds
RatiosIn
From
Logistic
Regression Models: Predicting the Association
of Characteristics of Communities With Presence of a Plasma Center In That Community
Variables
(1)
(2)
(3)
Income-to-Poverty
Percent Poverty <50%

1.040***
(.003)

1.043***
(.003)

1.040***
(.003)

Percent Poverty 50–99%

1.032***
(.005)

1.053***
(.006)

1.044***
(.006)

Percent Poverty 100–200%

1.035***
(.006)

1.053***
(.005)

1.045***
(.005)

Percent Black non-Hispanic

1.001
(.002)

1.003
(.002)

1.001
(.001)

Percent Hispanic

0.999
(.006)

1.010
(.006)

1.013***
(.004)

Percent Other

0.997
(.008)

0.994
(.009)

1.008
(.004)

Percent HS and/or Some College

---

1.045***
(.006)

1.033***
(.007)

Percent More than BA

---

1.050***
(.006)

1.033***
(.006)

Race and Ethnicity

Education

Urban/Rural Designation
Urban

---

---

9.297***
(2.105)

State controls

---

---

X

Constant

0.002

.00002

.00002

Observations
71,590
71,590
68,372
*** p<0.001, **p<0.01, * p<0.05
Reference category for income-to-poverty is percent poverty >200%
Reference category for race and ethnicity is White non-Hispanic
Reference category for educational attainment is percent < high school
Reference category for urban is percent rural
Robust standard errors are in parentheses
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compared to the fraction with less than a high school degree. Thus,
after controlling for income-to-poverty and race and ethnicity, the
odds of a plasma center being located in a community is positively associated with educational attainment. Finally, given that 96.8
percent of plasma centers in the U.S. are located in urban census
tracts, the odds ratio for the urban variable is large and statistically
significant beyond the .001 level.

Discussion
This study establishes that there is a clear linkage between the
location of plasma centers in the United States—the most important
market for the industry—and the presence of disadvantage. Census
tracts with higher levels of individuals just above the poverty line,
as well as higher levels of individuals in poverty and deep poverty,
were most likely to have a plasma center. In the absence of data on
the demographic characteristics of the actual people who sell their
blood plasma, this study expands our understanding of the characteristics of the people who are most likely to donate plasma—those
who are poor. This finding allows researchers to begin to interrogate the impact of plasma donation on the donor population, an
area of research that remains largely unexplored. Interestingly, in
multivariate models, economic deprivation appears to be a stronger
predictor of the location of plasma centers than does the race or
ethnicity of those living in a particular census tract.
Counter-intuitively, however, higher levels of education are
associated with greater odds of a plasma center being located in a
particular community, after controlling for the level of poverty and
other factors. Anecdotal evidence suggests that low-income student
populations are likely to engage in plasma donations. It may be that
plasma centers are more likely to be located in areas where there are
campuses with lower levels of economic resources. However, further
investigation of these issues—preferably with individual level data—
is warranted.
An understanding of the donor population carries compelling
public health implications because evidence on the short- and longterm health repercussions experienced by plasma donors is largely
absent from the literature. Because likely donors are presumably
poor, additional evidence on the impact of plasma donation on

68

Journal of Sociology & Social Welfare

vulnerable bodies must be considered. The ongoing COVID-19 pandemic highlights the vulnerability of poor Americans, whose social
and environmental circumstances have historically led to worse
health outcomes (Abrams & Szefler, 2020; Raifman & Raifman,
2020). This is due to a range of factors, from decreased access to
health care services to an increased likelihood of experiencing
chronic health conditions (Adler & Newman, 2002).
Pharmaceutical companies that manufacture and profit from the
sale of plasma protein therapies have little incentive to investigate
this line of inquiry further; their focus is on the patient, not the donor. While there is an abundance of scholarship that examines the
benefits of plasma-derived products for patients, deeper examination of how plasma donation impacts purveyors of the raw material
that patients and pharmaceutical companies depend on is equally
important. However, the privatized nature of the pharmaceutical
industry hinders access to donor data, hampering efforts for independent research in this area. Still, generating this kind of data is
paramount to ensuring that low-income donors are not inadvertently
debilitating their bodies in an effort to combat their poverty.
In the absence of evidence examining the ramifications of plasma donation to donor health, we encourage policymakers to consider the ethical implications of the reliance of low-income Americans
on plasma donations. To safeguard the well-being of likely donors,
policymakers should continue to expand policies that have sought
to mitigate the rise in hardship during the COV I D pandemic, such
as the 2021 expansion of the child tax credit.
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